Taking a Stepwise Approach to Managing Chronic Hand Eczema
Adam Friedman, MD, FAAD, outlines a stepwise approach to treating chronic hand eczema, from vehicle selection to systemic therapies and future innovations.
Orit Markowitz, MD, Explains How a Color Wheel Approach Can Sharpen Dermoscopic Decision-Making
Orit Markowitz, MD, shares how her color wheel method boosts diagnostic clarity in dermoscopy by simplifying how clinicians assess benign lesions.
Dermatologic Evaluation Leads to Early Detection of Breast Cancer Metastasis
A poster at SDPA highlights that dermatologists play a vital role in early detection of metastatic breast cancer, with skin changes often serving as the initial clue of internal disease recurrence.
Chronic Hand Eczema or Something Else? Adam Friedman, MD, FAAD, Shares Diagnostic Tips for Differentiating
Adam Friedman, MD, FAAD, breaks down how to differentiate chronic hand eczema from similar conditions using history, morphology, and key clinical clues.
Emerging Insights into Apremilast’s Efficacy for Early Oligoarticular Psoriatic Arthritis Across BMI Spectrums
Apremilast improved joint symptoms and quality of life in patients with early oligoarticular PsA, with consistent efficacy across all BMI categories.
Overcoming Prior Authorizations: Janelle Ball Shares Strategies for Streamlining Dermatology Workflows
Janelle Ball of BC Educators offers actionable tips to boost prior authorization success and improve patient support in dermatology practices.
Day 1 Recap: SDPA Annual Summer Dermatology Conference 2025
Catch up on coverage from the first day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.
Addressing Cutaneous Squamous Cell Carcinoma Through Early Detection and Treatment
A poster at SDPA 2025 highlights the importance of early biopsy and genetic testing in aggressive cSCC, even in young patients without classic risk factors.
Almirall Shares Real-World Data at 2025 International Congress of Dermatology
Almirall showcased groundbreaking research on atopic dermatitis, psoriasis, and actinic keratosis at the 2025 ICD.
DFD-29 Data Analysis Highlights Efficacy in Rosacea Regardless of Patient Differences in Body Weight
DFD-29 showed strong efficacy in rosacea regardless of body weight in 2 phase 3 trials, outperforming both placebo and doxycycline.
From Conference to Clinic: Eileen Cheever, MPAS, PA-C, Looks Ahead to Pearls Offered at SDPA Summer Meeting
Eileen Cheever, MPAS, PA-C, previews the SDPA Summer Dermatology Conference, calling it a can't-miss opportunity to learn, network, and reconnect.
POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2025?
Click here to answer our poll and let us know what you're looking forward to at the SDPA's summer conference.
Inside SDPA Summer 2025: Dermatology Times Board Member Presenters
Join Dermatology Times at SDPA 2025 as our expert board members take the stage to share clinical insights, pearls, and practice-changing perspectives.
Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect
The conference aimed at providing dermatology physician assistants with the latest in the specialty begins today in Washington, DC.
Clinical Pearls from the 2025 Fall Clinical PA/NP Meeting: Day 3
Jamie Restivo, MPAS, PA-C, shares her key takeaways from the final day of the recent Fall Clinical PA/NP Conference in Orlando, Florida.
Q&A Part 1: Reviewing the Significance of Lebrikizumab for Patients With Skin of Color, With Anabela Cardoso, MD
Anabela Cardoso, MD, shares data from the phase 3b ADmirable trial—the first study to evaluate the safety and efficacy of lebrikizumab in patients with moderate to severe AD and pigmented skin.
Recap: 2025 Revolutionizing Atopic Dermatitis Conference
Catch up on all updates and advancements shared at this year's Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee.
Clinical Pearls from the 2025 Fall Clinical PA/NP Meeting: Day 2
Jamie Restivo, MPAS, PA-C, shares her key takeaways from the second day of the recent Fall Clinical PA/NP Conference in Orlando, Florida.
Christina Feser, DO, Shares Therapeutic Advances in Hidradenitis Suppurativa From SCALE 2025
At SCALE 2025, Christina Feser, DO, FAAD, FAOCD, spotlighted the rapidly expanding pipeline of diverse therapies for patients with HS.
Q&A: Peter Lio, MD, on Safety in Pediatric AD Management and the Promise of Precision Medicine
Discover insights from Peter Lio, MD, on precision medicine in pediatric atopic dermatitis and the promising role of ruxolitinib at the RAD 2025 Conference.